Add Your Heading Text Here

RPM Dashboard
Article

How to Use Shared Decision-Making to Improve Healthcare

5 min read

Healthcare providers are certainly experts in the field, professionally trained to collect and analyze data on patients and recommend care options they believe best meet patients’ needs. But the patient also plays a role, providing input based on their values and desired health outcomes. The physician-centered approach of the past has begun to evolve, shifting to a more collaborative model called shared decision-making. Let’s take a look at how shared decision-making is improving healthcare.

What Is Shared Decision-Making?

Shared decision-making describes a collaborative communication and decision-making process between a healthcare provider and a patient. During shared decision-making, the provider offers the patient clear, detailed information about their health condition and options for treatment, including the benefits and drawbacks of each course of action. The care team seeks to understand the patient’s concerns and how their values and health goals influence treatment decisions. Together, the patient and physician come to a shared agreement on the best course of action and work collaboratively to implement the decision.

Using the SHARE Approach to Improve Patient-Provider Shared Decision-Making

The SHARE Approach was developed by the Agency for Healthcare Research and Quality (AHRQ) as a framework to support healthcare providers in integrating shared decision-making into their daily practice. This acronym embodies the best practices that make this approach to physician-facilitated decision-making so effective.

Seek your patient’s participation

The cardinal principle of the SHARE Approach is inviting your patient to engage in the process. They may choose not to, and that’s okay. But every interaction should begin with an invitation to take part in the process. After the problem has been presented, let the patient know there is more than one treatment option and their input is valued.

Help your patient explore and compare treatment options

Options always exist. In nearly every circumstance, there’s more than one possibility for how treatment proceeds. Begin by listing the options in writing, explaining the benefits and drawbacks of each along with the expected outcomes. Avoid medical jargon, use visual aids like charts or graphs, and incorporate decision aid tools to break down complex decisions. Asking your patient to explain in their own words what each option would entail can help you gauge the level of understanding to ensure your patient has an accurate understanding of the choices presented.

Assess your patient’s values and preferences

Discovering what’s important to your patient can help providers guide further discussion on treatment options to reach a medically-sound consensus that aligns with patient values. Start the discussion by asking open-ended questions, responding with empathy as patients share what’s most important to them as it relates to their medical condition and the treatment options available. Demonstrating active listening and empathy helps build patient trust, a key asset needed to move forward with treatment once an agreement has been reached.

Reach a decision with your patient

Once values have been expressed and treatment options presented, ask if the patient is ready to make a decision. They may need additional time to consider what’s been discussed, conferring with family members or others in their support network. If a decision isn’t made, set a date in the near future when their preferred treatment option can be expressed.

Evaluate your patient’s decision

Once a treatment decision has been made and treatment has begun, monitor the effectiveness of the chosen option and identify how well it’s performing. Be prepared to revisit the decision, helping the patient evaluate if additional options need to be considered in light of how the chosen treatment is progressing.

How Does Shared Decision-Making Help Patients and Providers?

Shared decision-making offers numerous advantages to both patients and healthcare providers. This cooperative approach actively engages all stakeholders to create care plans that support medical best practices and align with the needs and values of patients.

Aligns with informed consent best practices

Informed consent is required before any medical care, treatment, or services are provided. Shared decision-making supports the informed consent process by actively engaging the patient in decisions related to achieving their desired health outcomes. As patients and providers collaborate, patients are able to ask questions, receive information on the pros and cons of each option presented, and assist in choosing the one that best aligns with what’s most important to them.

Improves quality of patient care

Shared decision-making combines the expertise of the healthcare provider with the values, concerns, and input of the patient. This process helps to strengthen the trust and confidence the patient has in the quality of care they receive, fostering a stronger patient-provider relationship. By taking time to listen and learn, the healthcare provider gains valuable information about the patient they can use to guide the discussion towards the option most likely to meet the patient’s health objectives.

Helps address disparities in healthcare

Some patients face significant barriers to accessing care. These could include lack of reliable transportation, lack of trust in the healthcare system, significant work or childcare obligations, or concerns about the affordability of proposed treatments. Healthcare providers who take the time to listen are better equipped to refer patients to community resources that can alleviate these constraints or tailor treatment recommendations that take important extenuating circumstances into account.

Boosts patient engagement

Ultimately, a collaborative approach helps boost patient engagement. When patients are listened to and validated, they’re more likely to actively participate in their care. This heightened engagement can take the form of keeping scheduled medical appointments, greater treatment plan compliance, and greater levels of participation in lifestyle changes needed to reach mutually agreed-upon health goals.

How Withings Health Solutions Supports Shared Decision-Making

Withings connected devices collect and transmit key health metrics. These connected devices provide physicians and patients with valuable information that plays an important role in the shared decision-making process.

Easy to use, engaging device designs increase patient engagement

Our connected devices are designed to activate high levels of patient engagement. Their simple design makes it easy for patients to unlock the full potential of remote patient monitoring technology.

Multiple connectivity options

With Wi-Fi, cellular, and Bluetooth connectivity options, providers can pair patients with devices that feature the best connectivity option for them, improving adoption rates.

Extensive collection of remote patient monitoring devices

Withings has a comprehensive line of smart connected devices, including blood pressure monitors, scales, sleep mat, and activity trackers, that may be easily incorporated into a remote patient monitoring program.

Unlocking the Full Potential of Shared Decision-Making

Encouraging patients to engage with providers as equal partners in the medical decision-making process unlocks a host of benefits for both parties. Healthcare providers are better equipped to provide treatment that aligns with patient health goals and values. And active input results in patients feeling empowered, with confidence that the treatment they chose to pursue will best support their desired health outcomes.

Learn how Withings Health Solutions can help support shared decision-making.

Don’t miss out,  subscribe to get the latest content updates.  

Related Content

WP_Query Object ( [query] => Array ( [post_type] => post [post_status] => publish [orderby] => date [order] => DESC [ignore_sticky_posts] => 1 [post__not_in] => Array ( [0] => 375 ) [cat] => 18 [posts_per_page] => 3 ) [query_vars] => Array ( [post_type] => post [post_status] => publish [orderby] => date [order] => DESC [ignore_sticky_posts] => 1 [post__not_in] => Array ( [0] => 375 ) [cat] => 18 [posts_per_page] => 3 [error] => [m] => [p] => 0 [post_parent] => [subpost] => [subpost_id] => [attachment] => [attachment_id] => 0 [name] => [pagename] => [page_id] => 0 [second] => [minute] => [hour] => [day] => 0 [monthnum] => 0 [year] => 0 [w] => 0 [category_name] => articles [tag] => [tag_id] => [author] => [author_name] => [feed] => [tb] => [paged] => 0 [meta_key] => [meta_value] => [preview] => [s] => [sentence] => [title] => [fields] => all [menu_order] => => [category__in] => Array ( ) [category__not_in] => Array ( ) [category__and] => Array ( ) [post__in] => Array ( ) [post_name__in] => Array ( ) [tag__in] => Array ( ) [tag__not_in] => Array ( ) [tag__and] => Array ( ) [tag_slug__in] => Array ( ) [tag_slug__and] => Array ( ) [post_parent__in] => Array ( ) [post_parent__not_in] => Array ( ) [author__in] => Array ( ) [author__not_in] => Array ( ) [search_columns] => Array ( ) [suppress_filters] => [cache_results] => 1 [update_post_term_cache] => 1 [update_menu_item_cache] => [lazy_load_term_meta] => 1 [update_post_meta_cache] => 1 [nopaging] => [comments_per_page] => 50 [no_found_rows] => ) [tax_query] => WP_Tax_Query Object ( [queries] => Array ( [0] => Array ( [taxonomy] => category [terms] => Array ( [0] => 18 ) [field] => term_id [operator] => IN [include_children] => 1 ) ) [relation] => AND [table_aliases:protected] => Array ( [0] => wp_term_relationships ) [queried_terms] => Array ( [category] => Array ( [terms] => Array ( [0] => 18 ) [field] => term_id ) ) [primary_table] => wp_posts [primary_id_column] => ID ) [meta_query] => WP_Meta_Query Object ( [queries] => Array ( ) [relation] => [meta_table] => [meta_id_column] => [primary_table] => [primary_id_column] => [table_aliases:protected] => Array ( ) [clauses:protected] => Array ( ) [has_or_relation:protected] => ) [date_query] => [request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (375) AND ( wp_term_relationships.term_taxonomy_id IN (18) ) AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish')) GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 0, 3 [posts] => Array ( [0] => WP_Post Object ( [ID] => 2015 [post_author] => 11 [post_date] => 2025-06-12 15:39:12 [post_date_gmt] => 2025-06-12 15:39:12 [post_content] =>

Chronic Kidney Disease stage 5 on dialysis (CKD5D) presents one of the most complex and high-risk scenarios in modern medicine. Among the many challenges faced by these patients, cardiovascular disease (CVD) stands out as the leading cause of mortality—a stark reminder of the systemic stress that accompanies kidney failure and dialysis.

 

But what if technology could help bridge the gap between dialysis sessions, offering clinicians a window into the patient's health in real-time? An article in Frontiers in Nephrology explores exactly that—highlighting the transformative potential of digital health technologies to monitor and manage CKD5D patients beyond the clinic.

 

The Hidden Risks Between Dialysis Sessions

For CKD5D patients, the risks of CVD are amplified by both traditional and disease-specific factors:

 

  • Traditional risks like hypertension, diabetes, and obesity.

  • CKD-specific risks such as inflammation, fluid overload, protein-energy wasting and vascular calcification.

  • The dialysis process itself, which induces rapid fluid shifts, blood pressure fluctuations, and metabolic imbalances.

Current clinical care models often focus on in-center dialysis data, leaving a crucial blind spot during the interdialytic period—a time when many adverse events begin to develop unnoticed.

 

A New Monitoring Paradigm: The Withings Toolkit

The article introduces a compelling case for home-based, connected health technologies—specifically, the Withings toolkit. This suite of medical-grade, consumer-friendly devices allows CKD patients to monitor key health indicators in the comfort of their homes:

 

  • Weight, body composition and ECG monitoring with the BodyScan smart scale.

  • Blood pressure, heart rate and survey responses for added context via BPM Pro 2.

  • Sleep quality and breathing event metrics using the Sleep Rx.

All data is seamlessly uploaded to the Withings Remote Patient Monitoring platform, providing healthcare providers and researchers with real-time, longitudinal insights into a patient’s well-being.

 

Why This Matters: Real-World Clinical Benefits

1. Early Detection of Complications

Weight gain could signal fluid retention, but muscle loss could indicate protein-energy wasting. A sudden spike in blood pressure or irregular heartbeat might indicate arrhythmias or volume overload. Poor sleep patterns could reflect apnea or restless leg syndrome—conditions with known ties to CKD.

2. Personalized, Data-Driven Care

These devices enable a dynamic view of health trends, allowing clinicians to tailor treatments proactively rather than reactively. Medication adjustments, fluid restrictions, or further diagnostics can be made with greater confidence.

3. Patient Empowerment

When patients can see and understand their own data, they become more engaged in their care. This promotes better self-management, increased treatment adherence, and a stronger sense of control over their condition.

4. Systemic Healthcare Advantages

Remote monitoring can reduce emergency visits and hospitalizations, easing the burden on overtaxed healthcare systems and offering a cost-effective alternative to frequent in-person evaluations.

 

The Future: Digital Tools as Standard of Care?

While still in its early stages, this integration of digital health into CKD care reflects a broader movement toward remote, preventative, and personalized medicine. The Withings case study serves as a promising example of how everyday technology can be adapted to serve complex clinical needs.

 

However, as the authors note, more clinical trials are needed to validate these tools in nephrology settings, establish protocols for data use, and ensure equitable access across diverse patient populations.

 

Final Thoughts

As we face growing rates of kidney disease and limited nephrology resources, connected health technologies offer a lifeline—not just to patients, but to an entire care infrastructure in need of modernization.

 

The Withings toolkit is more than a gadget suite; it's a glimpse into the future of chronic disease management, where data flows continuously, care is adaptive, and patients are active participants in their own health journey.

 

References
 Article: Frontiers in Nephrology, 2023 - DOI: 10.3389/fneph.2023.1148565

Interested in partnering with us?

Contact Us [post_title] => Revolutionizing Chronic Kidney Disease Management with Digital Health Tools: The Withings Case Study [post_excerpt] => Chronic Kidney Disease stage 5 on dialysis (CKD5D) presents one of the most complex and high-risk scenarios in modern medicine.But what if technology could help bridge the gap between dialysis sessions, offering clinicians a window into the patient's health in real-time? [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => revolutionizing-chronic-kidney-disease-management-with-digital-health-tools-the-withings-case-study [to_ping] => [pinged] => [post_modified] => 2025-06-12 15:41:31 [post_modified_gmt] => 2025-06-12 15:41:31 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=2015 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 2012 [post_author] => 11 [post_date] => 2025-06-03 19:17:23 [post_date_gmt] => 2025-06-03 19:17:23 [post_content] =>

Introduction

 

Diabetic foot ulcers (DFUs) are a major and often debilitating complication of diabetes, contributing significantly to patient morbidity, mortality, and healthcare costs. Despite advancements in diabetes care, the incidence of DFUs remains high, with a substantial impact on quality of life and healthcare resources. A recent study published in the journal Frontiers in Endocrinology compared the use of electrochemical skin conductance (ESC) to the current standards in DFU detection. The current method for assessing DFU risk primarily involves clinical examination, including the monofilament test, which is subjective and dependent on the examiner’s skills. Therefore, there is a need for objective, reproducible, and reliable methods for early detection of at-risk patients.

 

One of the many complications of diabetes is peripheral neuropathy, which, if left untreated, can lead to DFUs. Electrochemical Skin Conductance (ESC) is a promising non-invasive diagnostic tool that can be used to assess autonomic nerve activity. ESC is measured in-clinic using Sudoscan, which assesses small fiber peripheral neuropathies, specifically the innervation around the sweat glands, by stimulating the glands and measuring the conductance (in µS) of chloride ions contained in the sweat. Lower ESC values indicate more severe neuropathy. This study investigates the association between ESC and DFU risk stratification, offering a potential new approach to managing and preventing diabetic foot complications.

Methods

 

This study was a retrospective analysis involving 2,149 diabetic patients from four clinics in Greater Paris University Hospitals, the largest hospital system in Europe and one of the largest in the world. The primary aim was to evaluate the relationship between ESC measurements and DFU risk, as classified using the 2016 International Working Group on Diabetic Foot (IWGDF) grading system. This grading system assigns DFU risk based on clinical evaluation, including the presence of neuropathy, ulceration, and other factors.

To assess the predictive performance of ESC in DFU risk stratification, the study incorporated a range of factors: age, sex, type of diabetes, and results from the monofilament test, which is a standard assessment of peripheral neuropathy. The study employed regression and Receiver Operating Characteristic (ROC) analyses to explore the predictive value of ESC measurements for different DFU risk categories.

 

Results

 

The study revealed a significant correlation between ESC values and DFU risk grades (p<0.001). Specifically, lower FESC values were associated with higher grades of DFU risk, suggesting that reduced sweat gland function, indicative of small fiber neuropathy, plays a role in the progression of foot ulcers in diabetic patients.

 

One of the most noteworthy findings of this study was that ESC measurements were able to identify patients at risk for DFUs who would not have been classified as high risk using the standard IWGDF grading system. Specifically, ESC detected autonomic dysfunction and small fiber nerve involvement in 43% patients classified as grade 0 (13% with severe cases of neuropathy), who otherwise showed no obvious signs of risk through traditional assessments, showing better granularity in the lower grades for better risk stratification.

 

The findings of this study suggest that Electrochemical Skin Conductance (ESC) provides a valuable, reproducible, and operator-independent tool for assessing DFU risk. ESC measurements offer an objective method for identifying early signs of small fiber neuropathy, a critical factor in the development of DFUs. Unlike traditional risk stratification, which relies heavily on clinical judgment and may overlook early-stage neuropathy, ESC can detect subtle changes in nerve function that precede visible foot ulcers.

 

The ability of ESC to detect at-risk patients in the grade 0 category, who would otherwise be overlooked by conventional classification methods, highlights its potential role in preventing DFUs. By identifying patients with early-stage nerve dysfunction, ESC could facilitate earlier intervention, potentially reducing the incidence of foot ulcers, amputations, and associated healthcare costs.

 

The ability to detect DFU risk early using ESC shows promise for the prevention of amputation.Therefore, we conclude that feet skin conductance is a relevant parameter for detecting diabetic foot syndrome, specifically at an early stage when there is still no presence of feet ulceration or wounds. A recent meta-analysis on ESC supports this conclusion, indicating that ESC, when combined with temperature measurements, serves as a valuable tool for the early detection of diabetic foot syndrome. ESC can be measured in-clinic, using Sudoscan, and at home using Withings Body Pro 2. Measuring ESC through home use of the Body Pro 2 scale allows for additional data collection and better assessment of trends and progression between appointments. Through this enhanced monitoring of DFU risk, care teams can better risk-stratify and provide targeted care that could prevent amputations and complications.

Interested in partnering with us?

Contact Us [post_title] => Electrochemical Skin Conductance as a Novel Tool for Diabetic Foot Ulcer Risk Stratification and Prevention [post_excerpt] => Diabetic foot ulcers (DFUs) are a major and often debilitating complication of diabetes, contributing significantly to patient morbidity, mortality, and healthcare costs.Electrochemical Skin Conductance (ESC) is a promising non-invasive diagnostic tool that can be used to assess autonomic nerve activity. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => electrochemical-skin-conductance-as-a-novel-tool-for-diabetic-foot-ulcer-risk-stratification-and-prevention [to_ping] => [pinged] => [post_modified] => 2025-06-16 13:31:21 [post_modified_gmt] => 2025-06-16 13:31:21 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=2012 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 2005 [post_author] => 11 [post_date] => 2025-05-29 18:17:36 [post_date_gmt] => 2025-05-29 18:17:36 [post_content] =>

Menopause can significantly impact sleep, blood pressure, and body composition—and it goes far beyond hot flashes.

As estrogen and progesterone levels decline, the risk of obstructive sleep apnea (OSA) increases. These hormones help keep airway muscles strong and support stable breathing during sleep. When they drop, the airway is more likely to collapse during the night. Combined with menopause-related weight gain, this can significantly heighten the risk. According to the Sleep Foundation and Mayo Clinic, postmenopausal women are more prone to sleep apnea, even if they hadn’t previously experienced symptoms.

 

Menopause also increases the risk of hypertension. Lower estrogen levels reduce blood vessel flexibility, making it harder for blood to flow efficiently. Coupled with changes in weight, cholesterol, and insulin sensitivity, blood pressure tends to rise. The American Heart Association highlights that the risk of heart disease, including high blood pressure, climbs sharply in postmenopausal women—making routine monitoring all the more important.

 

Body composition also shifts during menopause. Fat tends to accumulate around the abdomen—even if overall weight remains stable—due to hormonal changes. This increase in visceral fat, which surrounds internal organs, is linked to elevated risks of cardiovascular disease, type 2 diabetes, and certain cancers. A University of Pittsburgh study found that for every 20% increase in abdominal fat, artery thickness, a key marker of heart disease risk, also increased. The Mayo Clinic reinforces the importance of addressing these changes through exercise, strength training, and healthy eating.

 

Monitoring these health changes is crucial for comprehensive menopause care. Withings Health Solutions can help. Withings offers clinically validated devices that make it easy to track vital health metrics from home. Body Pro 2 measures not just weight, but also body fat, visceral fat and muscle mass—providing a deeper understanding of your cardiovascular health. Sleep Rx aids in the detection of sleep apnea without requiring a wearable, while the BPM Pro 2 enables simple, accurate blood pressure monitoring.

 

Connected health devices offer a powerful way to enhance care and demonstrate measurable outcomes. As menopause impacts everything from sleep and blood pressure to weight and long-term cardiovascular health, cellular-connected devices—like Body Pro 2, BPM Pro 2, and Sleep Rx—enable real-time tracking of key metrics. These insights help patients and users better manage symptoms and allow care teams to personalize support. Just as importantly, aggregated health data can validate the impact of your solution, making it easier to show ROI to employers and insurers and improve engagement across populations.

Interested in partnering with us?

Contact Us [post_title] => The Need for Remote Patient Monitoring in Menopause Care [post_excerpt] => Menopause can significantly impact sleep, blood pressure, and body composition—and it goes far beyond hot flashes. Connected devices can enable comprehensive care and proof of ROI for menopause benefits. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => the-need-for-remote-patient-monitoring-in-menopause-care [to_ping] => [pinged] => [post_modified] => 2025-05-29 18:19:03 [post_modified_gmt] => 2025-05-29 18:19:03 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=2005 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 3 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 2015 [post_author] => 11 [post_date] => 2025-06-12 15:39:12 [post_date_gmt] => 2025-06-12 15:39:12 [post_content] =>

Chronic Kidney Disease stage 5 on dialysis (CKD5D) presents one of the most complex and high-risk scenarios in modern medicine. Among the many challenges faced by these patients, cardiovascular disease (CVD) stands out as the leading cause of mortality—a stark reminder of the systemic stress that accompanies kidney failure and dialysis.

 

But what if technology could help bridge the gap between dialysis sessions, offering clinicians a window into the patient's health in real-time? An article in Frontiers in Nephrology explores exactly that—highlighting the transformative potential of digital health technologies to monitor and manage CKD5D patients beyond the clinic.

 

The Hidden Risks Between Dialysis Sessions

For CKD5D patients, the risks of CVD are amplified by both traditional and disease-specific factors:

 

  • Traditional risks like hypertension, diabetes, and obesity.

  • CKD-specific risks such as inflammation, fluid overload, protein-energy wasting and vascular calcification.

  • The dialysis process itself, which induces rapid fluid shifts, blood pressure fluctuations, and metabolic imbalances.

Current clinical care models often focus on in-center dialysis data, leaving a crucial blind spot during the interdialytic period—a time when many adverse events begin to develop unnoticed.

 

A New Monitoring Paradigm: The Withings Toolkit

The article introduces a compelling case for home-based, connected health technologies—specifically, the Withings toolkit. This suite of medical-grade, consumer-friendly devices allows CKD patients to monitor key health indicators in the comfort of their homes:

 

  • Weight, body composition and ECG monitoring with the BodyScan smart scale.

  • Blood pressure, heart rate and survey responses for added context via BPM Pro 2.

  • Sleep quality and breathing event metrics using the Sleep Rx.

All data is seamlessly uploaded to the Withings Remote Patient Monitoring platform, providing healthcare providers and researchers with real-time, longitudinal insights into a patient’s well-being.

 

Why This Matters: Real-World Clinical Benefits

1. Early Detection of Complications

Weight gain could signal fluid retention, but muscle loss could indicate protein-energy wasting. A sudden spike in blood pressure or irregular heartbeat might indicate arrhythmias or volume overload. Poor sleep patterns could reflect apnea or restless leg syndrome—conditions with known ties to CKD.

2. Personalized, Data-Driven Care

These devices enable a dynamic view of health trends, allowing clinicians to tailor treatments proactively rather than reactively. Medication adjustments, fluid restrictions, or further diagnostics can be made with greater confidence.

3. Patient Empowerment

When patients can see and understand their own data, they become more engaged in their care. This promotes better self-management, increased treatment adherence, and a stronger sense of control over their condition.

4. Systemic Healthcare Advantages

Remote monitoring can reduce emergency visits and hospitalizations, easing the burden on overtaxed healthcare systems and offering a cost-effective alternative to frequent in-person evaluations.

 

The Future: Digital Tools as Standard of Care?

While still in its early stages, this integration of digital health into CKD care reflects a broader movement toward remote, preventative, and personalized medicine. The Withings case study serves as a promising example of how everyday technology can be adapted to serve complex clinical needs.

 

However, as the authors note, more clinical trials are needed to validate these tools in nephrology settings, establish protocols for data use, and ensure equitable access across diverse patient populations.

 

Final Thoughts

As we face growing rates of kidney disease and limited nephrology resources, connected health technologies offer a lifeline—not just to patients, but to an entire care infrastructure in need of modernization.

 

The Withings toolkit is more than a gadget suite; it's a glimpse into the future of chronic disease management, where data flows continuously, care is adaptive, and patients are active participants in their own health journey.

 

References
 Article: Frontiers in Nephrology, 2023 - DOI: 10.3389/fneph.2023.1148565

Interested in partnering with us?

Contact Us [post_title] => Revolutionizing Chronic Kidney Disease Management with Digital Health Tools: The Withings Case Study [post_excerpt] => Chronic Kidney Disease stage 5 on dialysis (CKD5D) presents one of the most complex and high-risk scenarios in modern medicine.But what if technology could help bridge the gap between dialysis sessions, offering clinicians a window into the patient's health in real-time? [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => revolutionizing-chronic-kidney-disease-management-with-digital-health-tools-the-withings-case-study [to_ping] => [pinged] => [post_modified] => 2025-06-12 15:41:31 [post_modified_gmt] => 2025-06-12 15:41:31 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=2015 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 48 [max_num_pages] => 16 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => 1 [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => 1 [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 2b339e0bd7099d470733fc11d664a69b [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) [query_cache_key:WP_Query:private] => wp_query:136f0c24f2bf4e4600a4787d6dc44b35:0.06210900 17528561530.06200400 1752856153 )
Article

Revolutionizing Chronic Kidney Disease Management with Digital Health Tools: The Withings Case Study

Read More
Article

Electrochemical Skin Conductance as a Novel Tool for Diabetic Foot Ulcer Risk Stratification and Prevention

Read More
Article

The Need for Remote Patient Monitoring in Menopause Care

Read More

Interested in partnering with Withings Health Solutions?

Contact Us

References

References

  1. Withings internal study
About withings health solutions
For developers
For researchers
FOR PROFESSIONALS
© 2025 Withings All rights reserved.
Terms & Conditions Privacy Policy Cookie Policy Set Cookies
Linkedin

Withings On-The-Go

Our patient-centric care solution utilizes portable Withings cellular devices that are not tied to a single patient. Instead, care teams can use one device to collect and transmit data for an unlimited number of individuals. The integrated cellular connectivity automatically directs the data into the correct patient’s medical record, simplifying data collection and improving care delivery regardless of the setting.
Interested? Contact Us